(+)-pilocarpine multiple interactions EXP 6480464 Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA], Pirenzepine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA] CTD PMID:7968354 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of EGR2 mRNA CTD PMID:7968354 (-)-demecolcine increases expression ISO RGD:1352442 6480464 Demecolcine results in increased expression of EGR2 mRNA CTD PMID:23649840 (S)-nicotine increases expression ISO RGD:733541 6480464 Nicotine results in increased expression of EGR2 mRNA CTD PMID:17456735 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of EGR2 mRNA CTD PMID:27840820 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1352442 6480464 Dinitrochlorobenzene results in decreased expression of EGR2 mRNA CTD PMID:17374397 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:733541 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:28801915 17beta-estradiol affects expression ISO RGD:733541 6480464 Estradiol affects the expression of EGR2 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EGR2 mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:733541 6480464 Estradiol results in increased expression of EGR2 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:1352442 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of EGR2 mRNA more ... CTD PMID:20404318 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EGR2 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733541 6480464 Tetrachlorodibenzodioxin affects the expression of EGR2 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects methylation ISO RGD:1352442 6480464 Tetrachlorodibenzodioxin affects the methylation of EGR2 5' UTR more ... CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352442 6480464 Tetrachlorodibenzodioxin affects the expression of EGR2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352442 6480464 Tetrachlorodibenzodioxin results in decreased expression of EGR2 mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733541 6480464 Tetrachlorodibenzodioxin results in decreased expression of EGR2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733541 6480464 Tetrachlorodibenzodioxin results in increased expression of EGR2 mRNA CTD PMID:16962184 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352442 6480464 Tetrachlorodibenzodioxin results in increased expression of EGR2 mRNA CTD PMID:20106945 , PMID:30096437 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine multiple interactions ISO RGD:733541 6480464 Risperidone inhibits the reaction [Toluene promotes the reaction [4-iodo-2 more ... CTD PMID:32980479 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine increases expression ISO RGD:733541 6480464 4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of EGR2 protein CTD PMID:32980479 2-butoxyethanol increases expression ISO RGD:733541 6480464 n-butoxyethanol results in increased expression of EGR2 mRNA CTD PMID:19812364 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:733541 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of EGR2 mRNA CTD PMID:20188158 3-methylcholanthrene increases expression ISO RGD:733541 6480464 Methylcholanthrene results in increased expression of EGR2 mRNA CTD PMID:29554273 3alpha-hydroxy-5beta-pregnan-20-one increases expression EXP 6480464 Pregnanolone results in increased expression of EGR2 mRNA, Pregnanolone results in increased expression of EGR2 protein CTD PMID:17478888 4,4'-sulfonyldiphenol affects methylation ISO RGD:733541 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of EGR2 gene CTD PMID:31683443 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1352442 6480464 Oxazolone results in decreased expression of EGR2 mRNA CTD PMID:17374397 4-nitrophenol decreases expression ISO RGD:733541 6480464 4-nitrophenol results in decreased expression of EGR2 mRNA CTD PMID:34673133 5-azacytidine increases expression ISO RGD:1352442 6480464 Azacitidine results in increased expression of EGR2 mRNA CTD PMID:20823114 5alpha-pregnane-3,20-dione increases expression EXP 6480464 5-alpha-Dihydroprogesterone results in increased expression of EGR2 mRNA, 5-alpha-Dihydroprogesterone results in increased expression of EGR2 protein CTD PMID:17478888 7,12-dimethyltetraphene multiple interactions ISO RGD:733541 6480464 [CYP1B1 protein affects the susceptibility to 9 more ... CTD PMID:27891153 8-Br-cAMP increases expression ISO RGD:1352442 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR2 mRNA CTD PMID:20147733 , PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of EGR2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of EGR2 mRNA CTD PMID:32151602 aflatoxin B1 affects expression ISO RGD:1352442 6480464 Aflatoxin B1 affects the expression of EGR2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1352442 6480464 Aflatoxin B1 results in increased expression of EGR2 mRNA CTD PMID:21632981 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of EGR2 mRNA CTD PMID:20488242 , PMID:22664269 all-trans-retinoic acid increases expression ISO RGD:1352442 6480464 Tretinoin results in increased expression of EGR2 mRNA CTD PMID:21934132 more ... amiodarone increases expression ISO RGD:1352442 6480464 Amiodarone results in increased expression of EGR2 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EGR2 mRNA CTD PMID:16483693 aripiprazole increases expression EXP 6480464 Aripiprazole results in increased expression of EGR2 mRNA CTD PMID:17868501 aristolochic acid A decreases expression ISO RGD:1352442 6480464 aristolochic acid I results in decreased expression of EGR2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1352442 6480464 Arsenic affects the methylation of EGR2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1352442 6480464 Arsenic affects the methylation of EGR2 gene CTD PMID:25304211 arsenous acid multiple interactions ISO RGD:1352442 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of EGR2 mRNA] CTD PMID:19350554 arsenous acid decreases expression ISO RGD:1352442 6480464 Arsenic Trioxide results in decreased expression of EGR2 mRNA CTD PMID:19128835 , PMID:19350554 atropine multiple interactions EXP 6480464 Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA] CTD PMID:7968354 azathioprine increases expression ISO RGD:1352442 6480464 Azathioprine results in increased expression of EGR2 mRNA CTD PMID:22623647 baicalein decreases expression ISO RGD:733541 6480464 baicalein results in decreased expression of EGR2 mRNA CTD PMID:24560969 bathocuproine disulfonic acid multiple interactions ISO RGD:1352442 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] CTD PMID:15477007 bazedoxifene increases expression ISO RGD:1352442 6480464 bazedoxifene results in increased expression of EGR2 mRNA CTD PMID:19914376 benzene decreases expression ISO RGD:733541 6480464 Benzene results in decreased expression of EGR2 mRNA CTD PMID:15120971 , PMID:15122651 benzene increases expression ISO RGD:1352442 6480464 Benzene results in increased expression of EGR2 mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:733541 6480464 Benzo(a)pyrene results in decreased expression of EGR2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:733541 6480464 Benzo(a)pyrene results in increased methylation of EGR2 3' UTR, Benzo(a)pyrene results in increased methylation of EGR2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1352442 6480464 Benzo(a)pyrene affects the methylation of EGR2 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1352442 6480464 Benzo(a)pyrene results in increased methylation of EGR2 5' UTR, Benzo(a)pyrene results in increased methylation of EGR2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1352442 6480464 Benzo(a)pyrene results in increased expression of EGR2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:733541 6480464 Benzo(a)pyrene results in increased expression of EGR2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EGR2 mRNA CTD PMID:21839799 beryllium sulfate increases expression ISO RGD:1352442 6480464 beryllium sulfate results in increased expression of EGR2 mRNA CTD PMID:16314022 bis(2-chloroethyl) sulfide increases expression ISO RGD:733541 6480464 Mustard Gas results in increased expression of EGR2 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1352442 6480464 Diethylhexyl Phthalate results in decreased expression of EGR2 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EGR2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:733541 6480464 bisphenol A results in decreased expression of EGR2 mRNA CTD PMID:35598803 bisphenol A affects methylation ISO RGD:733541 6480464 bisphenol A affects the methylation of EGR2 promoter CTD PMID:27334623 bleomycin A2 affects expression ISO RGD:733541 6480464 Bleomycin affects the expression of EGR2 mRNA CTD PMID:26345256 bortezomib decreases expression ISO RGD:733541 6480464 Bortezomib results in decreased expression of EGR2 mRNA CTD PMID:20830808 bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of EGR2 mRNA, Bortezomib results in decreased expression of EGR2 protein CTD PMID:20830808 bucladesine multiple interactions ISO RGD:1352442 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EGR2 mRNA CTD PMID:20823114 butanal increases expression ISO RGD:1352442 6480464 butyraldehyde results in increased expression of EGR2 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:733541 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR2 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA] CTD PMID:25451590 cadmium atom increases expression ISO RGD:1352442 6480464 Cadmium results in increased expression of EGR2 mRNA CTD PMID:21694771 cadmium atom multiple interactions ISO RGD:1352442 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1352442 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EGR2 mRNA CTD PMID:35301059 Calcimycin increases expression ISO RGD:733541 6480464 Calcimycin results in increased expression of EGR2 mRNA CTD PMID:25451590 Calcimycin multiple interactions ISO RGD:733541 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA] CTD PMID:25451590 carbon nanotube increases expression ISO RGD:733541 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of EGR2 mRNA CTD PMID:18500788 cerium trichloride decreases expression ISO RGD:733541 6480464 cerous chloride results in decreased expression of EGR2 mRNA CTD PMID:23573234 chloroprene decreases expression ISO RGD:733541 6480464 Chloroprene results in decreased expression of EGR2 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:733541 6480464 Chlorpyrifos results in decreased expression of EGR2 mRNA CTD PMID:20350560 choline multiple interactions ISO RGD:733541 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EGR2 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of EGR2 mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1352442 6480464 Cisplatin results in increased expression of EGR2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1352442 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of EGR2 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:733541 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of EGR2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EGR2 mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:733541 6480464 Clofibrate results in decreased expression of EGR2 mRNA CTD PMID:17585979 clozapine affects expression ISO RGD:733541 6480464 Clozapine affects the expression of EGR2 mRNA CTD PMID:19401217 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of EGR2 protein CTD PMID:17028028 cocaine increases expression ISO RGD:733541 6480464 Cocaine results in increased expression of EGR2 mRNA CTD PMID:20056891 cocaine increases expression EXP 6480464 Cocaine results in increased expression of EGR2 mRNA CTD PMID:27899881 cocaine affects expression EXP 6480464 Cocaine affects the expression of EGR2 mRNA CTD PMID:20187946 copper atom increases expression ISO RGD:1352442 6480464 Copper results in increased expression of EGR2 CTD PMID:24403277 copper(0) increases expression ISO RGD:1352442 6480464 Copper results in increased expression of EGR2 CTD PMID:24403277 copper(II) sulfate increases expression ISO RGD:1352442 6480464 Copper Sulfate results in increased expression of EGR2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1352442 6480464 Asbestos, Crocidolite results in increased expression of EGR2 mRNA CTD PMID:18687144 crocidolite asbestos increases expression ISO RGD:733541 6480464 Asbestos, Crocidolite results in increased expression of EGR2 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of EGR2 mRNA CTD PMID:27523638 cycloheximide increases expression ISO RGD:1352442 6480464 Cycloheximide results in increased expression of EGR2 mRNA CTD PMID:19350554 cyclophosphamide decreases expression ISO RGD:733541 6480464 Cyclophosphamide results in decreased expression of EGR2 mRNA CTD PMID:21041162 cyclosporin A multiple interactions ISO RGD:733541 6480464 Cyclosporine inhibits the reaction [Zymosan results in increased expression of EGR2 mRNA] CTD PMID:17312158 cyclosporin A increases expression ISO RGD:1352442 6480464 Cyclosporine results in increased expression of EGR2 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression ISO RGD:733541 6480464 Cyclosporine results in decreased expression of EGR2 mRNA CTD PMID:25224403 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of EGR2 mRNA CTD PMID:21865292 cyproconazole decreases expression EXP 6480464 cyproconazole results in decreased expression of EGR2 mRNA CTD PMID:22664269 DDT increases expression EXP 6480464 DDT results in increased expression of EGR2 mRNA CTD PMID:30207508 dexamethasone decreases expression ISO RGD:733541 6480464 Dexamethasone results in decreased expression of EGR2 mRNA CTD PMID:21041162 , PMID:22733784 dexamethasone decreases expression ISO RGD:1352442 6480464 Dexamethasone results in decreased expression of EGR2 mRNA CTD PMID:25047013 diarsenic trioxide multiple interactions ISO RGD:1352442 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of EGR2 mRNA] CTD PMID:19350554 diarsenic trioxide decreases expression ISO RGD:1352442 6480464 Arsenic Trioxide results in decreased expression of EGR2 mRNA CTD PMID:19128835 , PMID:19350554 dibutyl phthalate increases expression ISO RGD:733541 6480464 Dibutyl Phthalate results in increased expression of EGR2 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of EGR2 mRNA CTD PMID:21266533 , PMID:21745491 dichloroacetic acid increases expression ISO RGD:733541 6480464 Dichloroacetic Acid results in increased expression of EGR2 mRNA CTD PMID:28962523 dieldrin increases expression ISO RGD:1352442 6480464 Dieldrin results in increased expression of EGR2 mRNA CTD PMID:31068361 diethylstilbestrol decreases expression ISO RGD:733541 6480464 Diethylstilbestrol results in decreased expression of EGR2 mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:733541 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EGR2 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of EGR2 mRNA CTD PMID:33729688 diuron increases expression EXP 6480464 Diuron results in increased expression of EGR2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1352442 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR2 mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:733541 6480464 Doxorubicin affects the expression of EGR2 mRNA CTD PMID:15033991 doxorubicin decreases expression ISO RGD:1352442 6480464 Doxorubicin results in decreased expression of EGR2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of EGR2 mRNA CTD PMID:29391264 ethanol affects expression ISO RGD:733541 6480464 Ethanol affects the expression of EGR2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1352442 6480464 Ethyl Methanesulfonate results in increased expression of EGR2 mRNA CTD PMID:23649840 eugenol decreases expression ISO RGD:1352442 6480464 Eugenol results in decreased expression of EGR2 mRNA CTD PMID:17374397 ferric oxide increases expression ISO RGD:733541 6480464 ferric oxide analog results in increased expression of EGR2 mRNA CTD PMID:24525745 , PMID:25086211 fluoranthene multiple interactions ISO RGD:733541 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of EGR2 mRNA CTD PMID:28329830 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of EGR2 mRNA CTD PMID:22664269 folic acid multiple interactions ISO RGD:733541 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EGR2 mRNA CTD PMID:20938992 folic acid affects expression ISO RGD:733541 6480464 Folic Acid deficiency affects the expression of EGR2 mRNA CTD PMID:32304770 formaldehyde increases expression ISO RGD:1352442 6480464 Formaldehyde results in increased expression of EGR2 mRNA CTD PMID:17938736 , PMID:28937961 formaldehyde multiple interactions ISO RGD:1352442 6480464 Formaldehyde inhibits the reaction [H3-3A protein binds to EGR2 promoter] CTD PMID:28937961 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of EGR2 mRNA CTD PMID:18499655 furan increases methylation EXP 6480464 furan results in increased methylation of EGR2 gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of EGR2 mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of EGR2 mRNA CTD PMID:33387578 haloperidol affects expression ISO RGD:733541 6480464 Haloperidol affects the expression of EGR2 mRNA CTD PMID:19401217 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of EGR2 mRNA CTD PMID:18208916 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of EGR2 protein CTD PMID:17028028 hydrogen peroxide affects expression ISO RGD:1352442 6480464 Hydrogen Peroxide affects the expression of EGR2 mRNA CTD PMID:20044591 ionomycin multiple interactions ISO RGD:1352442 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] more ... CTD PMID:15477007 L-methionine multiple interactions ISO RGD:733541 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EGR2 mRNA CTD PMID:20938992 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of EGR2 mRNA CTD PMID:22641619 lead diacetate increases methylation EXP 6480464 lead acetate results in increased methylation of EGR2 gene CTD PMID:29571894 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of EGR2 mRNA CTD PMID:35283115 manganese(II) chloride increases expression ISO RGD:733541 6480464 manganese chloride results in increased expression of EGR2 mRNA CTD PMID:28801915 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of EGR2 mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions ISO RGD:1352442 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EGR2 mRNA CTD PMID:20823114 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of EGR2 mRNA CTD PMID:15644446 , PMID:19564919 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of EGR2 gene CTD PMID:19589859 methylisothiazolinone increases expression ISO RGD:1352442 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of EGR2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1352442 6480464 methylmercuric chloride results in increased expression of EGR2 mRNA CTD PMID:28001369 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of EGR2 mRNA CTD PMID:31378766 Monobutylphthalate affects expression ISO RGD:733541 6480464 monobutyl phthalate affects the expression of EGR2 mRNA CTD PMID:19162170 morphine increases expression ISO RGD:733541 6480464 Morphine results in increased expression of EGR2 mRNA CTD PMID:22454534 N-acetyl-L-cysteine multiple interactions ISO RGD:1352442 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of EGR2 mRNA] CTD PMID:19350554 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of EGR2 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium increases methylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of EGR2 gene CTD PMID:28801915 N-Nitrosopyrrolidine increases expression ISO RGD:1352442 6480464 N-Nitrosopyrrolidine results in increased expression of EGR2 mRNA CTD PMID:32234424 naphthalene increases expression ISO RGD:733541 6480464 naphthalene results in increased expression of EGR2 mRNA CTD PMID:18978301 nicotine increases expression ISO RGD:733541 6480464 Nicotine results in increased expression of EGR2 mRNA CTD PMID:17456735 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of EGR2 mRNA CTD PMID:20303128 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of EGR2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:733541 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EGR2 mRNA, TTPA protein affects the reaction [Ozone results in increased expression of EGR2 mRNA] CTD PMID:19555225 , PMID:34911549 p-chloromercuribenzoic acid multiple interactions ISO RGD:1352442 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR2 mRNA CTD PMID:27188386 palytoxin increases expression ISO RGD:733541 6480464 palytoxin results in increased expression of EGR2 mRNA CTD PMID:26436198 paracetamol multiple interactions ISO RGD:733541 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of EGR2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EGR2 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of EGR2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1352442 6480464 Acetaminophen results in increased expression of EGR2 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:733541 6480464 Acetaminophen affects the expression of EGR2 mRNA CTD PMID:17562736 pentanal increases expression ISO RGD:1352442 6480464 pentanal results in increased expression of EGR2 mRNA CTD PMID:26079696 pentane-2,3-dione increases expression EXP 6480464 2, 3-pentanedione results in increased expression of EGR2 mRNA CTD PMID:25710175 phenobarbital decreases expression ISO RGD:733541 6480464 Phenobarbital results in decreased expression of EGR2 mRNA CTD PMID:19270015 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1352442 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] more ... CTD PMID:15477007 phorbol 13-acetate 12-myristate increases expression ISO RGD:1352442 6480464 Tetradecanoylphorbol Acetate results in increased expression of EGR2 mRNA CTD PMID:31068361 phosgene affects expression ISO RGD:733541 6480464 Phosgene affects the expression of EGR2 mRNA CTD PMID:16300373 pirenzepine multiple interactions EXP 6480464 Pirenzepine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA] CTD PMID:7968354 pirinixic acid increases expression ISO RGD:733541 6480464 pirinixic acid results in increased expression of EGR2 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:733541 6480464 Pregnenolone Carbonitrile results in decreased expression of EGR2 mRNA CTD PMID:22698814 progesterone increases expression EXP 6480464 Progesterone results in increased expression of EGR2 mRNA, Progesterone results in increased expression of EGR2 protein CTD PMID:17478888 progesterone multiple interactions ISO RGD:1352442 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EGR2 mRNA CTD PMID:20660070 propanal increases expression ISO RGD:1352442 6480464 propionaldehyde results in increased expression of EGR2 mRNA CTD PMID:26079696 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1352442 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA], pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] CTD PMID:15477007 quercetin increases expression ISO RGD:1352442 6480464 Quercetin results in increased expression of EGR2 mRNA CTD PMID:21632981 quercitrin increases expression ISO RGD:1352442 6480464 quercitrin results in increased expression of EGR2 mRNA CTD PMID:25193878 rifampicin multiple interactions ISO RGD:1352442 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR2 mRNA CTD PMID:21127053 risperidone decreases expression EXP 6480464 Risperidone results in decreased expression of EGR2 protein CTD PMID:17028028 risperidone multiple interactions ISO RGD:733541 6480464 Risperidone inhibits the reaction [Toluene promotes the reaction [4-iodo-2, 5-dimethoxyphenylisopropylamine results in increased expression of EGR2 protein]] CTD PMID:32980479 SB 431542 multiple interactions ISO RGD:1352442 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGR2 mRNA CTD PMID:27188386 SCH 23390 decreases expression EXP 6480464 SCH 23390 results in decreased expression of EGR2 mRNA CTD PMID:19564919 scopolamine decreases expression EXP 6480464 Scopolamine results in decreased expression of EGR2 mRNA CTD PMID:17540011 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of EGR2 mRNA CTD PMID:15967596 Shikonin multiple interactions ISO RGD:733541 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR2 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA] CTD PMID:25451590 silicon dioxide decreases expression ISO RGD:1352442 6480464 Silicon Dioxide analog results in decreased expression of EGR2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:733541 6480464 Silicon Dioxide results in increased expression of EGR2 mRNA CTD PMID:19073995 more ... silicon dioxide increases expression ISO RGD:1352442 6480464 Silicon Dioxide analog results in increased expression of EGR2 mRNA CTD PMID:23806026 silicon dioxide affects expression ISO RGD:733541 6480464 Silicon Dioxide affects the expression of EGR2 mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:1352442 6480464 Silver results in increased expression of EGR2 mRNA CTD PMID:26014281 , PMID:26551752 silver atom increases expression ISO RGD:733541 6480464 Silver results in increased expression of EGR2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1352442 6480464 Silver results in increased expression of EGR2 mRNA CTD PMID:26014281 , PMID:26551752 silver(0) increases expression ISO RGD:733541 6480464 Silver results in increased expression of EGR2 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:733541 6480464 sodium arsenate results in decreased expression of EGR2 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1352442 6480464 sodium arsenite results in increased expression of EGR2 mRNA CTD PMID:29301061 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of EGR2 mRNA CTD PMID:27257137 Soman increases expression EXP 6480464 Soman results in increased expression of EGR2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:733541 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EGR2 mRNA more ... CTD PMID:21641980 , PMID:26378955 sunitinib increases expression ISO RGD:1352442 6480464 Sunitinib results in increased expression of EGR2 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of EGR2 mRNA CTD PMID:21865292 temozolomide decreases expression ISO RGD:1352442 6480464 Temozolomide results in decreased expression of EGR2 mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EGR2 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:733541 6480464 Carbon Tetrachloride results in increased expression of EGR2 mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of EGR2 mRNA CTD PMID:20830808 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EGR2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:733541 6480464 titanium dioxide analog results in increased expression of EGR2 mRNA, titanium dioxide results in increased expression of EGR2 mRNA CTD PMID:23409001 more ... titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of EGR2 mRNA CTD PMID:30012374 toluene multiple interactions ISO RGD:733541 6480464 Risperidone inhibits the reaction [Toluene promotes the reaction [4-iodo-2 more ... CTD PMID:32980479 topotecan increases expression EXP 6480464 Topotecan results in increased expression of EGR2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of EGR2 mRNA CTD PMID:25729387 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of EGR2 mRNA CTD PMID:22664269 triazoles decreases expression EXP 6480464 Triazoles results in decreased expression of EGR2 mRNA CTD PMID:17343997 tributylstannane increases expression ISO RGD:1352442 6480464 tributyltin results in increased expression of EGR2 mRNA CTD PMID:28011154 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of EGR2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1352442 6480464 trichostatin A results in decreased expression of EGR2 mRNA CTD PMID:24935251 trichostatin A affects expression ISO RGD:1352442 6480464 trichostatin A affects the expression of EGR2 mRNA CTD PMID:28542535 trichostatin A increases expression ISO RGD:1352442 6480464 trichostatin A results in increased expression of EGR2 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:733541 6480464 trimellitic anhydride results in increased expression of EGR2 mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:733541 6480464 triptonide results in increased expression of EGR2 mRNA CTD PMID:33045310 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions EXP 6480464 Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA] CTD PMID:7968354 urethane increases expression ISO RGD:1352442 6480464 Urethane results in increased expression of EGR2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:733541 6480464 Valproic Acid results in decreased expression of EGR2 mRNA CTD PMID:15799026 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of EGR2 mRNA CTD PMID:35594946 valproic acid increases expression ISO RGD:1352442 6480464 Valproic Acid results in increased expression of EGR2 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:1352442 6480464 Valproic Acid results in decreased expression of EGR2 mRNA CTD PMID:24935251 , PMID:28001369 valproic acid affects expression ISO RGD:1352442 6480464 Valproic Acid affects the expression of EGR2 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1352442 6480464 Valproic Acid results in increased methylation of EGR2 gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of EGR2 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of EGR2 mRNA CTD PMID:30207508 zinc atom multiple interactions ISO RGD:1352442 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EGR2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1352442 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EGR2 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1352442 6480464 zoledronic acid results in increased expression of EGR2 mRNA CTD PMID:20977926